tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RLMD Stock Latest News

Relmada Therapeutics: Hold Rating Amid Uncertainty and Strategic Shifts
RatingsRelmada Therapeutics: Hold Rating Amid Uncertainty and Strategic Shifts
20d ago
RLMD
Relmada Therapeutics: Strategic Acquisitions and Pipeline Progress
PremiumCompany Announcements
Relmada Therapeutics: Strategic Acquisitions and Pipeline Progress
22d ago
RLMD
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
PremiumCompany Announcements
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
23d ago
RLMD
Relmada Therapeutics reports Q4 EPS (62c) vs. (84c) last year
PremiumThe Fly
Relmada Therapeutics reports Q4 EPS (62c) vs. (84c) last year
23d ago
RLMD
Relmada Therapeutics Secures Exclusive License for NDV-01
PremiumCompany Announcements
Relmada Therapeutics Secures Exclusive License for NDV-01
24d ago
8K
RLMD
Relmada Therapeutics licenses Phase 2 Bladder Cancer candidate from Trigone
PremiumThe FlyRelmada Therapeutics licenses Phase 2 Bladder Cancer candidate from Trigone
25d ago
RLMD
RLMD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RLMD Upcoming Earnings Report: What to Expect?
28d ago
RLMD
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
2M ago
ATAI
CMND
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
2M ago
ATAI
CMND
Relmada Therapeutics acquires Sepranolone from Asarina Pharma
PremiumThe Fly
Relmada Therapeutics acquires Sepranolone from Asarina Pharma
2M ago
RLMD
Relmada Therapeutics Acquires Sepranolone for CNS Portfolio
PremiumCompany Announcements
Relmada Therapeutics Acquires Sepranolone for CNS Portfolio
2M ago
8K
RLMD
Psychedelic: atai Life Sciences reports BPL-003 study results
PremiumThe Fly
Psychedelic: atai Life Sciences reports BPL-003 study results
3M ago
ATAI
CMND
Rising High: Exclusive talk with MSO ETHOS Cannabis
PremiumThe FlyRising High: Exclusive talk with MSO ETHOS Cannabis
3M ago
ACB
CGC
Rising High: Exclusive talk with pharmaceutical development company MIRA
Premium
The Fly
Rising High: Exclusive talk with pharmaceutical development company MIRA
3M ago
ACB
CGC
Relmada Therapeutics Strengthens Leadership with New COO
Premium
Company Announcements
Relmada Therapeutics Strengthens Leadership with New COO
3M ago
8K
RLMD
Rising High: Exclusive talk with biopharma company HMNC Brain Health
PremiumThe Fly
Rising High: Exclusive talk with biopharma company HMNC Brain Health
4M ago
ACB
CGC
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
4M ago
CMRX
GOEV
Rising High: Organigram acquires Motif Labs for C$90M upfront
PremiumThe Fly
Rising High: Organigram acquires Motif Labs for C$90M upfront
4M ago
ACB
CGC
Relmada Therapeutics commences exploration of strategic alternatives
PremiumThe Fly
Relmada Therapeutics commences exploration of strategic alternatives
4M ago
RLMD
Relmada Therapeutics Shifts Focus After Study Discontinuation
PremiumCompany AnnouncementsRelmada Therapeutics Shifts Focus After Study Discontinuation
4M ago
8K
RLMD
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
AGI
API
Rising High: Cannabis firms report quarterly earnings
Premium
The Fly
Rising High: Cannabis firms report quarterly earnings
5M ago
ACB
CGC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >